Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Ryan's View

View as an RSS Feed
View Ryan's View's Articles BY TICKER:
  • Neuralstem Rounding Second With Phase II ALS Trial
    on Thu, May 16 • CUR • 4 Comments
  • Biotechnology: Strong Fundamentals Are The Basis Of Strong Performance
    on Fri, May 3 • AMGN, ATHX, AZN • 5 Comments
  • Survival Strategies For Development Biotechs And How They Affect Share Prices
    on Thu, Mar 28 • AGEN, CLDX, GSK • 9 Comments
  • Phase II Trials Will Be Pivotal For These Stem Cell Companies
    on Wed, Mar 20 • ATHX, PSTI, STEM • 11 Comments
  • 4 Drug Delivery Companies That Deliver For Investors
    on Wed, Feb 27 • ALKS, AMGN, AZN • Comment!
  • Biotech Mid Caps, Dangerous Slippery Slopes
    on Tue, Feb 12 • ARIA, HSP, MDVN • 5 Comments
  • 4 Companies Ringing The Bell
    on Mon, Feb 4 • GAIN, GLAD, NWBO • 3 Comments
  • Stem Cell Therapy Companies: Underappreciated Outperformers
    on Tue, Jan 29 • AMBS.OB, ATHX, NBS • 11 Comments
  • Boardroom Insight Vital For EV Charging Companies
    on Wed, Jan 9 • CCGI.OB, ECTY • Comment!
  • This Week's Biotech Summary (December 16-21, 2012)
    on Wed, Dec 19, 2012 • ALXA, DMD, NBY • 9 Comments
  • Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learned
    on Sun, Dec 16, 2012 • CUR, DNDN, GALE • 9 Comments
  • Biotechnology In 2012: The Best Performing Industry
    on Tue, Dec 4, 2012 • ALIM, NWBO, PCYC • Comment!
  • The 'Local' Path To Mobile Marketing
    on Mon, Nov 19, 2012 • FB, GOOG, GRPN • 5 Comments
  • For NovaBay, Simplicity Is The Father Of Invention
    on Mon, Nov 12, 2012 • AGN, FRX, MRK • Comment!
  • Northwest's Stock May Be Heading North With Latest News On Trials
    on Thu, Oct 25, 2012 • NWBO • 3 Comments